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Abstract
Background: Birth weight is determined by the interplay between infant genetics and the intrauterine
environment and is associated with several health outcomes in later life. Many studies have reported an association
between birth weight and DNA methylation in infants and suggest that altered epigenetics may underlie
birthweight-associated health outcomes. However, birth weight is a relatively nonspecific measure of fetal growth
and consists of fat mass and fat-free mass which may have different effects on health outcomes which motivates
studies of infant body composition and DNA methylation. Here, we combined genome-wide DNA methylation
profiling of buccal cells from 47 full-term one-week old infants with accurate measurements of infant fat mass and
fat-free mass using air-displacement plethysmography.
Results: No significant association was found between DNA methylation in infant buccal cells and infant body
composition. Moreover, no association between infant DNA methylation and parental body composition or
indicators of maternal glucose metabolism were found.
Conclusions: Despite accurate measures of body composition, we did not identify any associations between infant
body fatness and DNA methylation. These results are consistent with recent studies that generally have identified
only weak associations between DNA methylation and birthweight. Although our results should be confirmed by
additional larger studies, our findings may suggest that differences in DNA methylation between individuals with
low and high body fatness may be established later in childhood.
Background
Epigenetic variations, such as DNA methylation, have
been associated with a growing number of chronic di-
seases and conditions, including obesity [1–5]. Interest-
ingly, the intrauterine environment may alter DNA
methylation patterns in the developing embryo and asso-
ciations between DNA methylation in neonatal blood
and maternal body mass index (BMI), gestational weight
gain and smoking have been reported [6, 7]. These asso-
ciations are supported by animal models in which diet-
induced epigenetic changes and their associated pheno-
types have been transmitted across multiple generations
[8–10] and epidemiological studies have hypothesized
that extremes in diet may result in altered disease risk in
subsequent generations, possibly via an epigenetic mech-
anism [11, 12]. Moreover, recent studies have identified
an association between neonatal blood DNA methylation
and birth weight [13, 14]. As birth weight is predictive of
several health outcomes later in life [15, 16], DNA
methylation has been proposed as a potential molecular
mechanism underlying these associations.
How DNA methylation changes may causally contribute
to fatness phenotypes in humans remains unresolved, but
a growing body of evidence supports the potential of
minor epigenetic changes in early development to cause
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large changes in body composition [17, 18]. Indeed, we
previously showed that subtle epigenetic variation in early
mouse development can result in profound changes in lit-
termate body composition [18]. Building on our work in
mouse, Pospisilik and colleagues [17] have demonstrated
that similar transcriptional variance during early develop-
ment could result in a stable bi-modal phenotype; obese
or not-obese. Importantly, identification of an imprinted
gene network as causal in the bi-modal phenotype and it’s
recapitulation in a cohort of lean and obese children [17],
highlights the potential of epigenetic dysregulation in gen-
eration of fat related phenotypes in human [19]. Genomic
imprinting as a source of epigenetic-driven alterations in
body composition are particularly attractive as DNA
methylation is essential for establishing and maintaining
genomic imprints and genetic loss of imprinting is
typically associated with over-growth and metabolic
phenotypes [20].
Birth weight is however a nonspecific measure of fetal
growth and consists of fat mass and fat-free mass. This
is of importance since fat mass and fat-free mass may
have different effects on health outcomes in adulthood
[21] as well as during childhood and infancy [22, 23].
Noteworthy, the commonly used surrogate measure for
body fatness, BMI, as well as birth weight are poor
markers of body fatness in infants [24, 25]. The lack of
accurate measurements of infant body composition may
underlie the typically weak and often divergent associa-
tions between DNA methylation and infant birth weight
[13, 14]. Therefore, we hypothesized that an accurate
measure of body fatness would provide stronger associ-
ation with infant DNA methylation. Hence, we measured
body fatness accurately using air-displacement plethys-
mography (ADP) in a cohort of healthy full-term infants
[26] and generated base-resolution genome-wide maps
of buccal cell DNA methylation from the same infants.
The advantage of ADP is that body composition (both
fat and fat-free body mass) can be measured accurately
in a quick and non-invasive manner [27, 28]. To help
identify factors that could influence in utero develop-
ment and associated DNA methylation patterns we also
used ADP to measure body composition in the fathers
and mothers in gestational week 32, as well as key mea-
sures of glucose metabolism and insulin resistance dur-
ing pregnancy.
Using our novel approach, we found no association be-
tween any measures of body fatness in infants and
neonatal buccal cell DNA methylation. Moreover, no as-
sociation between DNA methylation in infant buccal
cells and parental body composition or maternal insulin
resistance was identified. Thus, our findings suggest that
differences in DNA methylation between individuals
with low and high body fatness may be established later
in childhood.
Results
The DNA methylation profile of buccal cells fails to
separate newborns with high or low body fatness
In order to study the early programming effects of
body fatness in humans we characterized the DNA
methylation patterns of buccal cell isolated from
those infants identified as having the lowest (N = 23)
and highest (N = 24) body fatness in the PArents and
THeir OffSpring (PATHOS) study (Fig. 1a). Body fat-
ness was defined as fat mass (kg) divided by body
weight (kg). Characteristics of study participants are
summarized in Table 1. No differences in gestational
age (independent t-test; P = 0.22) or in the fat-free
mass index (i.e. fat-free mass normalized for height)
(independent t-test; P = 0.12) between infants with
low and high body fatness were observed. Further-
more, no statistically significant differences (independ-
ent t-test) in parental age, parental BMI, parental
body composition as well as maternal glycemia were
observed between infants with low and high body
fatness.
Genome-wide DNA methylation was determined
using llumina® 450 K DNA methylation microarrays.
As expected, principal components analysis (PCA)
did not cluster the data according to infant body
fatness group (Fig. 1b). Unsupervised hierarchical
clustering also showed no association with other po-
tential confounders of sex or microarray-based batch
effects (Fig. 1c). Thus, no global differences in DNA
methylation patterns were observed between infants
with high or low body fatness. We next attempted to
associate body fatness with DNA methylation levels
at individual CpG sites. Despite removal of non-
variable sites to increase sensitivity (Supplementary
Figure 1B, see methods), no significant associations
between DNA methylation levels and infant body
fatness (low versus high body fatness) were detected
(F-test, FDR < 0.05) (Fig. 1d). Thus, differences in in-
fant body fatness were not associated with global or
locus-specific changes in DNA methylation in buccal
cells.
Given the small sample size of the current study,
the absence of association observed may reflect a lack
of power to detect smaller yet biologically meaningful
associations. Thus, we next sought to determine if
those probes showing greatest rank association with
infant fatness were enriched for loci identified in pre-
vious large-scale EWAS of BMI. No overlap was
found between the top 1000 probes reported here and
the 156 probes showing statistically significant associ-
ation between BMI and methylation in the largest
EWAS of BMI to date [29]. Furthermore, we found
no significant overlap (N = 3, P > 0.05, Fishers exact
test) between the top 1000 probes identified here and
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those identified in the ALSPAC study of maternal
pre-pregnancy BMI and offspring blood DNA methy-
lation (N = 1649) [6]. Interestingly, there was also no
overlap between the significant probes identified in
the ALSPAC (N = 1649) study and the EWAS of BMI
and adverse outcomes of adiposity (N = 156).
Fig. 1 The DNA methylation profile of buccal cells fails to separate newborns with high or low body fatness. (a) Outline of experimental design:
Buccal cells were isolated from those newborns with the highest (N = 23) and lowest (N = 24) body fatness enrolled the PATHOS (PArents and
THeir OffSpring) study. Genomic DNA was isolated from buccal cells, bisulfite-treated and applied to Illumina® Infinium 450 k DNA methylation
arrays. (b) Principle components analysis failed to cluster methylation data by fatness (c) Unsupervised hierarchical clustering of the same data
also failed to separate subjects by body fatness, sex, fat mass index (FMI) or array. (d) Manhattan plot showing of association of genome-wide
DNA methylation levels with infant body fatness. No probes were significantly associated with body fatness after adjusting for multiple
correction (FDRADJUSTED = 0.05)
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Characterizing the association between parental
phenotype and infant DNA methylation
The in utero environment has been associated with both
infant size (e.g [26, 30, 31]) and methylation levels [6].
Thus, we investigated if the DNA methylation patterns
observed in infant buccal cells reflected maternal charac-
teristics during gestation. Again, no loci were signifi-
cantly associated with maternal BMI, fat mass index or
fat-free mass index (Linear regression, FDR < 0.05)
(Fig. 2a-c). Similarly, no association between maternal
insulin resistance and beta-cell function as measured
using HOMA-IR) in gestation al week 32 was observed
(Supplementary Figure 2A). Finally, there was essentially
no evidence for an association of paternal body
composition or other infant body composition variables
(than body fatness) with infant DNA methylation
(Supplementary Figure 2C).
Discussion
Obesity is a global public health issue and is strongly re-
lated to impaired health and quality of life [32]. Birth
weight has been related to DNA methylation in infancy
[13, 14] as well as health outcomes in later life, such as
obesity and mortality [15, 16]. Previous studies have gen-
erally reported weak associations between birth weight
and DNA methylation in infant blood despite very large
sample sizes [13, 14]. However, infants with similar birth
weight can have very different levels of body fatness
Table 1 Characteristic of the infants in the study
Infants with low body
fatness (n = 23)
Infants with high body
fatness (n = 24)
Value Value P-valuea
Infant characteristics
Birth weightb (g) 3320 ± 315 4045 ± 416 < 0.001
Gestational age at birth (week) 40.2 ± 1.1 40.6 ± 1.0 0.22
Female sex (n) 11 12
Male sex (n) 12 12
Age at measurement (week) 1.1 ± 0.2 1.0 ± 0.3 0.51
Weight at 1 wk. (g) 3271 ± 298 4024 ± 361 < 0.001
Length at 1 wk. (cm) 51.1 ± 1.2 52.4 ± 1.3 0.001
% fat mass at 1 wk. 6.5 ± 2.7 17.6 ± 1.6 < 0.001
BMI at 1 wk. (kg/m2) 12.5 ± 0.8 14.6 ± 1.1 < 0.001
Fat mass index at 1 wk. (kg/m2) 0.82 ± 0.36 2.57 ± 0.36 < 0.001
Fat-free mass index at 1 wk. (kg/m2) 11.7 ± 0.7 12.1 ± 0.8 0.12
Maternal characteristics
Age (year) 30.6 ± 3.3 30.6 ± 4.1 0.98
Pre-pregnancy BMI2 (kg/m2) 22.6 ± 3.3 22.6 ± 3.1 0.96
BMIc (kg/m2) 26.0 ± 3.6 26.7 ± 3.3 0.47
% fat massc 33.8 ± 5.2 33.9 ± 5.2 0.98
Fat mass indexc (kg/m2) 8.9 ± 2.5 9.2 ± 2.5 0.72
Fat-free mass indexc (kg/m2) 17.1 ± 1.6 17.5 ± 1.3 0.26
HOMA-IRc 1.7 ± 0.7 2.1 ± 0.9 0.74
Glycaemiac (mmol/L) 4.7 ± 0.3 4.8 ± 0.2 0.12
Paternal characteristics
Age (year) 33.9 ± 5.0 32.8 ± 4.4 0.43
BMIc (kg/m2) 25.5 ± 4.3 25.3 ± 4.7 0.47
% fat massc 23.7 ± 10.0 23.9 ± 8.8 0.98
Fat mass indexc (kg/m2) 6.4 ± 3.8 6.3 ± 3.6 0.94
Fat-free mass indexc (kg/m2) 19.1 ± 1.6 18.9 ± 1.8 0.70
BMI Body mass index, HOMA-IR homeostasis model assessment-insulin resistance
Values are mean ± SD or n
a Refers to the P value of an independent t-test
b Self-reported by the mother
c Measured when mother was in gestational week 32
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[33]. Consequently, we sought to investigate if accurate
assessment of body composition could reveal any bio-
logical meaningful associations between DNA methyla-
tion and body fatness in newborns.
This study is the first to directly test whether DNA
methylation differs between infants with low or high
body fatness. Using this novel approach, we did not
identify any differences in DNA methylation across the
body fatness categories. Moreover, no association be-
tween parental body composition and maternal glucose
homeostasis with DNA methylation in infants was ob-
served. Whereas our results are somewhat in contrast to
previous studies of birth weight and DNA methylation
in blood [13, 14], we note that the previously reported
differences in DNA methylation associated with birth
weight identified are few and typically too small to have
a functional impact on gene expression with little over-
lap between independent studies [14]. Our results may
also be compared with previous studies that have exam-
ined genetic variation in relation to adiposity in child-
hood. Although studies have linked a few loci to birth
weight these loci have generally not been associated with
adiposity later in life [34]. Furthermore, there has been
little evidence linking gene variants to infant body fat-
ness [26, 35]. Studies in older children have reported as-
sociations between adiposity and several gene variants
including single-nucleotide polymorphism in the FTO-
gene [36, 37] which is the strongest obesity associated
Fig. 2 No association between maternal phenotype and infant DNA methylation. (a-c) Manhattan plots showing lack of association
(FDRADJUSTED = 0.05) between DNA methylation levels and (a) maternal body mass index, (b) maternal fat mass index and (c) maternal fat-free
mass index
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gene variant in adulthood [34]. Interestingly, the influ-
ence of FTO gene variant on adiposity appears to be
small in infancy but strengthens considerably during
childhood [38]. These results may be reconciled with
our results and previous studies which have shown asso-
ciation between adiposity and DNA methylation in older
children which include studies of both blood [39, 40]
and saliva samples [41, 42].
The major strength of the current study is the well-
categorized cohort of parents and infants which also in-
cluded accurate measure of body composition [27, 43].
Nevertheless, the study also has several limitations. First,
an important limitation of the study is its relatively small
sample size (N = 47), which compromises the power of
the study to detect small, but significant associations be-
tween DNA methylation and body fatness. Calculating
significant difference in EWAS using DNA methylation
arrays is complex and no standard significance thresh-
olds exist. Using a recently described simulation-based
approach to estimating the 5% family-wise error rate for
methylation array studies, the current study has 80%
predicted power to detect > 5% methylation differences
at 25% of CpG sites on the array and > 2% methylation
differences at just 4% of sites [44]. Consequently, the
current study is limited to detection of relatively large
differences in DNA methylation between infant with low
and high body fatness. Second, although the study in-
cluded infants with a wide range in body fatness, they all
came from a well-nourished population which motivates
further studies in populations with a more heteroge-
neous nutritional status. Third, the use of buccal epithe-
lial cell (BEC) DNA obtained from buccal swabs, instead
of other relevant tissues such as adipose or liver tissue,
is a potential limitation of the study. Our use of BECs as
a surrogate tissue was motivated by several factors in-
cluding the relativity easy and non-invasive collection of
DNA [45] which was also supported by the fact that we
were able to collect DNA from all 209 infants in the
PATHOS study [26]. Moreover, a growing body of evi-
dence supports the use of BECs over blood in EWAS
[46–48]. DNA methylation patterns in blood are pro-
foundly different from those in most other somatic
tissues questioning their choice as a surrogate for non-
blood related phenotypes [46, 48]. BECs exhibit higher,
and more consistent inter-individual DNA methylation
variation, increasing the effective power of BEC EWAS
over blood EWAS. In addition, biological and technical
replicates of BECs show more stability between samples
than blood, reducing noise [49]. Finally, differentially
methylated regions (DMRs) in BECs more often overlap
known disease-associated SNPs than blood DMRs [47].
Although buccal swabs were carefully performed, BEC
preparations can be contaminated with non-epithelial
cells, such as lymphocytes, which may lower the
predictive power of the study, but would not be expected
to vary between groups.
Conclusion
In conclusion, this study reports no difference in
genome-wide DNA methylation between 1-week-old in-
fants with low and high body fatness. Although our find-
ings require confirmation by future larger studies, our
results indicate that potential differences in DNA methy-




This pilot study utilized data from a previous study
called the PATHOS (PArents and THeir OffSpring)
study, which investigated associations of parental and in-
fant body composition early in life [26, 50]. In order to
maximize the statistical power and since we hypothe-
sized that the largest differences in DNA methylation
would be between extremes in infant body fatness, we
selected the 24 infants (12 girls and 12 boys) with the
lowest body fatness (range: 0.9–9.8% fat mass) and the
24 infants (12 girls and 12 boys) with the highest body
fatness (range: 15.1–21.1% fat mass) at 1 week of age for
this study.
The study was approved by the Regional Ethics Com-
mittee (reference numbers: M187–07 and 2012/440–32),
Linköping and informed consent, witnessed and formally
documented, was obtained from the parents.
Body composition of infants and their parents
At 1 week of age, infant length and weight were assessed
using standardized procedures and subsequently, the
body composition of the infants was measuring using
ADP and the Fomon model (Pea Pod, COSMED USA,
Inc., Concord, CA, USA), see our previous study for
more detailed information [50]. The height, weight and
body composition of both mothers and fathers were
measured after an overnight fast when the mother was
in gestational week 32. Briefly, body composition was as-
sess by ADP (Bod Pod, COSMED USA, Inc., Concord,
CA, USA) as previously described [30, 50]. Furthermore,
a fasting blood sample was collected from the mother to
determine plasma glucose and serum insulin. None of
the mothers were diagnosed with gestational diabetes.
Maternal HOMA-IR (homeostasis model assessment-
insulin resistance) was calculated according to Matthews
et al. [51]. Maternal pre-pregnancy weight was self-
reported at the measurement in gestational week 32.
BMI [weight (kg)/height2 (m)], fat mass index [FMI; fat
mass (kg)/height2 (m)], and fat-free mass index [FFMI;
fat-free mass (kg)/height2 (m)] were calculated.
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DNA extraction and DNA methylation analysis
A buccal swab was performed on the infants and subse-
quently DNA was extracted using QuickExtract DNA
Extraction Solution 1.0 (Epicentre Biotechnologies,
Madison, WI, USA). DNA quality was assessed by using
Agilent Genomic DNA ScreenTape System and DNA
concentration was measured using Qubit fluorometer.
DNA was stored in – 20 °C for further analysis. 500 ng
of genomic DNA was bisulfate converted with EZ-96
DNA Methylation kit (Zymo Research, Irvine, CA, USA)
and genome wide DNA methylation analysis was per-
formed using the Infinium Human Methylation 450 K
BeadChip (Illumina, San Diego, CA, USA) according to
the manufacturer’s instructions.
Methylation data analysis
Illumina 450 K DNA methylation data was pre-
processed using functional normalization [52] as imple-
mented in minfi [53]. One sample did not pass quality
control and was excluded from further analyses (Supple-
mentary Figure 1A). Next, problematic probes were ex-
cluded based on general purpose masking [54] and only
autosomes were kept. Differentially methylated region
(DMR) analysis using the minfi bumphunter function
(cutoff = 0.2 and bootstraps (B) = 1000) [53] yielded only
two DMRs consisting of single probes with FWERs >
0.05 (data not shown), therefore we focused on single
CpGs instead. Differentially methylated probes (DMPs)
were identified using the minfi dmpFinder function
using default settings [53]. Briefly, continuous variables
(BMI, FMI, FFMI and log HOMA-IR) were tested with
linear regression and categorical variables (infant body
fatness group) were tested with F-tests. To increase stat-
istical power in identifying DMPs after multiple-testing
correction, invariant probes related to cell type were fil-
tered as previously described [55] but with a more strin-
gent requirement of at least 20% variability between the
10th and 90th percentile, this represented approximately
the top 5th percentile of variable CpGs. The remaining
20,027 filtered DMP P-values were false discovery rate
(FDR)-corrected to account for multiple testing.
Supplementary Information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12864-020-07169-7.
Additional file 1: Supplementary Figure 1. DNA methylation quality
control and pre-processing. (A) Density plot showing expected bi-modal
distribution of DNA methylation values in all samples except one (dashed
line) (top) and fraction of failed probe positions per sample based on de-
tection P-values (P > 0.01) (bottom). (B) Plot showing the variability cutoff
below which probes were excluded from linear regression studies of as-
sociation (see methods). Supplementary Figure 2. No association be-
tween parental phenotype and infant DNA methylation levels. (A)
Manhattan plot showing lack of association (FDRADJUSTED = 0.05) between
infant DNA methylation levels and maternal homeostatic model
assessment insulin resistance (HOMA-IR) score. (B) Manhattan plots show-
ing lack of association (FDRADJUSTED = 0.05) between DNA methylation
levels and infant body mass index, infant fat mass index and infant fat-
free mass index. (C) Manhattan plots showing lack of association (FDRAD-
JUSTED = 0.05) between DNA methylation levels and paternal body mass
index, paternal fat mass index and paternal fat-free mass index.
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